CureBay
CureBay is a Bhubaneswar-based rural healthtech company running 250+ tech-enabled village e-clinics across seven Indian states, where trained health workers connect patients to teleconsultations, diagnostics, pharmacy delivery and surgery coordination, with AI-assisted screening for skin, dental and hemoglobin conditions.
About
CureBay is a Bhubaneswar-based rural healthtech company running 250+ tech-enabled village e-clinics across seven Indian states, where trained health workers connect patients to teleconsultations, diagnostics, pharmacy delivery and surgery coordination, with AI-assisted screening for skin, dental and hemoglobin conditions. It has served over 1.7 million patients.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 4
Founders / team· 3
Funding history
- 2026-10-22Equity + Debt
Investors · IvyCap Ventures, Trifecta Capital, Alteria Capital, VentureSoul PartnersSource · biospectrumindia.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- CureBay
CureBay is a Bhubaneswar-based rural healthtech company running 250+ tech-enabled village e-clinics across seven Indian states, where trained health workers connect patients to teleconsultations, diagnostics, pharmacy delivery and surgery coordination, with AI-assisted screening for skin, dental and hemoglobin conditions. It has served over 1.7 million patients.
Equity + Debt · $45M · 2026-10
$45M
United States
BusinessLatest roundTotal raisedDate- MiSalud Health
Employee health benefits for employers with large Hispanic workforces in agriculture, manufacturing, hospitality and similar sectors: same-day bilingual telehealth (common illnesses, diabetes/hypertension chronic care management, prescription refills, nutrition and mental health support) and on-site health screenings, with AI assistance in the care guidance process, addressing Hispanic workers' lack of accessible, culturally adapted healthcare
$18M
$18M - Karoo Health
Value-based care platform for cardiovascular disease, integrating clinical/claims/pharmacy/patient data for early risk identification and coordinated care
Series A · $16M · 2026-07
$16M - Happy Health
Ring device for diagnosing and treating sleep apnea
Series A · $75M · 2026-08
$75M
China
BusinessLatest roundTotal raisedDate- 透彻未来
AI-based pathology image diagnosis services
Series A · $69M · 2024-06
$69M - SleepWell Technology Corp.
AI sleep health screening and brainwave intervention (smartphone face-scan screening + brainwave eye mask)
— - 睿心医疗
Developer of AI precision diagnosis and treatment platforms for cardiovascular and cerebrovascular disease and of vascular interventional surgical robots.
Strategic · 2026-07
—
Europe
BusinessLatest roundTotal raisedDate- Skin Analytics
AI tool that assists skin cancer detection by identifying skin lesions from images
Series B · $20M · 2025-04
$20M - Holifya
AI-driven digital obesity clinic with personalized GLP-1 weight-loss treatment management
$3M · 2026-09
$3M - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription, and automatic post-visit generation of medical records and diagnostic codes
Series B · $160M · 2026-09
$160M
Other / unspecified
BusinessLatest roundTotal raisedDate- Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing), with a company-operated network of hospitals and clinics and accompanying health insurance.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Ibex Medical Analytics
AI-based cancer diagnostics technology
Series C · $55M · 2023-09
$55M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.